DOI : 10.1055/s-00000094

Zeitschrift für Gastroenterologie

Issue 01 · Volume 58 · January 2020 DOI: 10.1055/s-009-45326

Deutsche Arbeitsgemeinschaft zum Studium der Leber (GASL)
36. Jahrestagung der Deutschen Arbeitsgemeinschaft zum Studium der Leber
Mainz, 14.–15.02.2020

Kongresspräsident: Prof. Dr. Peter Galle
Abstracts (HTML) List of Authors
3.4
Wang, S; Feng, R; Wang, S; Liu, H; Shao, C; Ebert, MPA; Ding, H; Dooley, S; Weng, H: FOXA2 replaces FXR to maintain BSEP expression on bile canaliculi in acute-on-chronic liver failure
3.5
Gehrke, N; Straub, BK; Waisman, A; Schuppan, D; Wörns, MA; Galle, PR; Schattenberg, JM: Hepatic IL-1 signaling in NAFLD is a driver of whole-body insulin resistance and adipose tissue inflammation.
3.6
Witzel, HR; Schwittai, I; Pawella, LM; Rausch, V; Mueller, S; Schattenberg, J; Hartmann, N; Schirmacher, P; Roth, W; Straub, BK: Lipid droplet proteins in alcoholic and non-alcoholic steatohepatitis in patients with polymorphisms in PNPLA3
3.7
Bopp, C; Rebholz, C; Weber, SN; Lammert, F: Abcg8 19 H Variante im Mausmodell: Größere Gallenblasenvolumina und gesteigerte biliäre Sterolkonzentrationen
3.8
Krawczyk, M; Schattenberg, JM; Schubert, L; Dikopoulos, N; Schwenzer, J; Muche, M; Wiegand, J; Felten, G; Heyne, R; Ingiliz, P; Schmidt, A; Stein, K; Manns, M; Zeuzem, S; Buggisch, P; Lammert, F; Hofmann, WP: PNPLA3 and HSD17B13 gene variants exert opposite effects on fatty liver phenotypes: results from the FLAG cohort
3.9
Myllys, M; Holland, CH; Saez-Rodriquez, J; Murad, W; Zaza, A; Hassan, R; Ahmed, YA; Abbas, T; Abdelrahim, EA; Schneider, KM; Jörg, R; Drasdo, D; Berres, ML; Trautwein, C; Hengstler, JG; Ghallab, A: Metabolic reprogramming in livers of mice with chronic liver disease
3.10
Adenugba, A; Hornung, M; Schlitt, H; Geissler, E; Hutchinson, J; Werner, J: Lipid-loaded Hepatocytes fail to Suppress IL-4 Production by Human CD4+ iNKT Cells
3.11
Chamulitrat, W; Seeßle, J; Javaheri-Haghighi, B; Döring, S; Zhu, X; Tuma-Kellner, S; Gan-Schreier, H; Schmitz, G; Liebisch, G; Stremmel, W; Herrmann, T: Intestinal deletion of fatty acid transport protein 4 in mice increases blood chylomicrons
3.12
Gan-Schreier, H; Staffer, S; Tuma-Kellner, S; Chamulitrat, W: Deletion of fatty acid transport protein 4 in HepG2 cells increases lipolysis lipids and lipoprotein secretion
3.13
Schuran, FA; Lommetz, C; Steudter, A; Wieschendorf, B; Schwinge, D; Lohse, AW; Schramm, C; Herkel, J; Carambia, A: Activation of the arylhydrocarbon receptor sensitizes to acetaminophen-induced acute liver failure
3.14
Lange, A; Adamek, E; Werner, J; Kunkel, J; Lange, M; Noerenberg, J; Vermehren, J; Weiss, TS: Evaluation of a piglet model for Parenteral Nutrition-associated Cholestasis (PNAC)
3.15
Gao, Y; Dooley, S; Hammad, S: Role of GPNMB in hepatic steatogenesis and cancer
3.16
Müntnich, L; Roderfeld, M; Tschuschner, A; Albrecht, J; Oruc, Z; Renz, H; Arneth, B; Pons-Kühnemann, J; Roeb, E: M30 als Biomarker für die nicht-invasive NAFLD-Diagnostik bei Patienten mit morbider Adipositas nach Roux-y-Magenbypass
3.17
Cai, C; Drexler, S; Gaitantzi, H; Rudolf, S; Luuk, H; Ebert, M; Breitkopf-Heinlein, K: Beneficial effects of high BMP-9 levels under diabetic and high fat conditions
3.18
Christidis, G; Karatayli, E; Hall, RA; Weber, SN; Lammert, F; Karatayli, SC: Fibroblast growth factor 21 response in a preclinical alcohol model of acute-on-chronic liver injury
3.19
Chen, C; Peccerella, T; Rausch, V; Mueller, S: H2O2, the major reactive oxygen species produced during alcohol metabolism induces autophagy without involving mTOR
3.20
Fromme, M; Arslanow, A; Hamesch, K; Mandorfer, M; Schneider, CV; Lindhauer, C; Woditsch, V; Kümpers, J; Bals, R; Janciauskiene, S; Reichert, M; Trauner, M; Trautwein, C; Lammert, F; Strnad, P: Metabolische Veränderungen bei Erwachsenen mit homozygotem Alpha1-Antitrypsinmangel (Pi*ZZ Genotyp)
3.21
Käser, R; Engels, F; Kilmer, S; Zoldan, K; Seifert, G; Fink, J; Marjanovic, G; Kabat, A; Pearce, E; Longerich, T; Thimme, R; Böttler, T: Progression of NAFLD and NASH is mediated by proinflammatory tissue-resident T cells
3.22
Burbaum, B; Schneider, CV; Hamesch, K; Fromme, M; Mandorfer, M; Reichert, M; Arslanow, A; Woditsch, V; Voß, J; Bals, R; Pereira, V; Carvão, J; Lammert, F; Trauner, M; Krag, A; Denk, H; Trautwein, C; Strnad, P: Europäische Studie: Heterozygoter Alpha-1-Antitrypsinmangel (Pi*MZ) führt zu einem intermediären Leber-Phänotyp
3.23
Hartmann, D; Zhang, XJ; Olsavsky, V; Wang, B; Engleitner, T; Öllinger, R; Schledzewski, K; Koch, PS; Rad, R; Schmid, RM; Goerdt, S; Hüser, N; Friess, H; Géraud, C; Figura, G von: Der angiokrine HGF-Signalweg steuert die Organ- und Körpergröße sowie die Hepatozytenproliferation
3.24
Irungbam, K; Roderfeld, M; Churin, Y; Glimm, H; Yüce, I; Morlock, G; Roeb, E: Abcb4-knockout reduces hepatic lipid steatosis in HBs transgenic mice
3.25
Fleißner, J; Schubert, S; Butt, E; Zernecke-Madsen, A; Geier, A; Hermanns, H: Apoe- vs. Ldlr-KO: The genetic background determines the function of Oncostatin M in the regulation of lipid homeostasis
3.26
Martin, A; Lang, S; Farowski, F; Wisplinghoff, H; Vehreschild, MJG; Krawczyk, M; Nowag, A; Kretzschmar, A; Herweg, J; Lammert, F; Goeser, T; Kasper, P; Steffen, HM; Demir, M: Phenotyping non-alcoholic fatty liver disease by the gut microbiota – ready for prime time?
3.27
Gaitantzi, H; Cai, C; Asawa, S; Böttcher, K; Ebert, M; Breitkopf-Heinlein, K: Human 3-dimensional liver organoids: in vitro model systems to study liver diseases
3.28
Bosse, L; Peters, K; Dombrowski, F; Ribback, S: Characterisation of enzyme activities in liver parencyhma of diabetic ChREBP-KO mice
3.29
Alonso-Peña, M; Geier, A; Hermanns, H: Suppression of bile acid-CoA:amino acid N-acyltransferase gene expression by Oncostatin M
3.30
Tang, X; Karuna, I; Quack, T; Grevelding, C; Kadesch, P; Roderfeld, M; Roeb, E: Schistosoma mansoni eggs modulate lipid metabolism in hepatocytes
3.31
Arezu Saberi, V; Ibrahim, S; Dayoub, R; Buchner, M; Melter, M; Weiss, TS: Augmenter of Liver Regeneration (ALR) reduziert die Gallensäure induzierte Apoptose
3.32
Spormann, L; Gebhardt, R; Matz-Soja, M: The interaction of Hedgehog and mTor signaling in healthy hepatocytes
3.33
Ott, F; Werner, K; Gericke, M; Gebhardt, R; Matz-Soja, M: Hedgehog Signaling as a mediator between liver and adipose tissue
3.34
Jahn, D; Vogt, M; Dorbath, D; Hermanns, H; Geier, A: Glucose and metformin differentially regulate FGF19 signaling in human HepG2 cells
3.35
Schumacher, A; Metzendorf, C; Ribback, S; Dombrowski, F: Investigation of the glycogen-associated proteome via proximity-biotinylation
3.36
Haderer, M; Gschwendtner, H; Kunst, C; Gülow, K; Müller-Schilling, M: E. coli bacteria trigger mucin reduction to promote a destabilized epithelial barrier in SBP
3.37
Leone, V; Kotsiliti, E; Singh, I; Li, X; Ali, A; Gallage, S; Pfister, D; Weber, A; Zitzelsberger, H; Unger, K; Heikenwälder, M: Antioxidant-based therapy in non-alcoholic steatohepatitis (NASH) and NASH-induced hepatocellular carcinoma development
3.38
Zibert, A; Guttmann, S; Schmidt, HH: New role of copper transporter ATP7B in lipid metabolism of enterocytes
3.39
Jördens, M; Pereira, J; Görg, B; Keitel, V; Häussinger, D: Effect of HE-relevant factors on GLAST clustering in cultured rat astrocytes